ArticleGels (Basel, Switzerland)2025
Encapsulation of Lactoferrin in Calcium-Alginate Microparticles and Its Release Therefrom Under Neutral and Mild Acidic Conditions: Synthesis, Characterization and Mathematical Modeling.
Article in Gels (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bovine Colostrum-Derived Lactoferrin Nanoparticles as a Novel Platform for Improved Pulmonary Delivery of Osimertinib.Cell biochemistry and biophysics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bio-based polymeric stimuli-responsive materials have attracted increasing interest, especially in the pharmacological and nutraceutical fields. These materials mainly consist of macromolecules capable of conformational and chemical changes in response to external signals. One active molecule mostly used in bio-related areas is lactoferrin (Lf), which is attracting attention due to its beneficial effects (antimicrobial, anti-inflammatory, and anti-carcinogenic) on the human body. Since pH or temperature in the human body can promote Lf degradation, encapsulation in a suitable system is required. A valid solution is to encapsulate the Lf in a polysaccharidic matrix such as alginate (ALG) thanks to its biocompatibility and easy gelation with bivalent cations. This work aims to encapsulate iron-depleted Lf in alginate gel microspheres for stability improvement by ionic cross-linking with Ca
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.